First human tests begin for vaccines targeting common virus linked to MS and cancer
NCT ID NCT06655324
Summary
This early-stage study is testing two new vaccine candidates (V350A and V350B) designed to prevent diseases caused by Epstein-Barr virus (EBV), which is linked to mononucleosis, multiple sclerosis, and certain cancers. The trial will enroll 200 healthy adults to primarily assess the safety and side effects of different vaccine doses. Researchers will also measure whether the vaccines trigger an immune response against EBV.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Alliance for Multispecialty Research, LLC ( Site 0008)
RECRUITINGKansas City, Missouri, 64114, United States
Contact Phone: •••-•••-••••
-
Alliance for Multispecialty Research, LLC ( Site 0009)
ACTIVE_NOT_RECRUITINGKnoxville, Tennessee, 37909, United States
-
Bio-Kinetic Clinical Applications, LLC dba QPS-MO ( Site 0016)
RECRUITINGSpringfield, Missouri, 65802, United States
Contact Phone: •••-•••-••••
-
California Clinical Trials Medical Group managed by PAREXEL ( Site 0011)
COMPLETEDGlendale, California, 91206, United States
-
Lynn Health Science Institute ( Site 0010)
RECRUITINGOklahoma City, Oklahoma, 73112, United States
Contact Phone: •••-•••-••••
-
QPS-MRA, LLC ( Site 0012)
ACTIVE_NOT_RECRUITINGMiami, Florida, 33143, United States
-
Remington-Davis, Inc. ( Site 0017)
RECRUITINGColumbus, Ohio, 43215, United States
Contact Phone: •••-•••-••••
-
Velocity Clinical Research Lincoln ( Site 0004)
RECRUITINGLincoln, Nebraska, 68510, United States
Contact Phone: •••-•••-••••
-
Velocity Clinical Research, Omaha ( Site 0005)
ACTIVE_NOT_RECRUITINGOmaha, Nebraska, 68134, United States
Conditions
Explore the condition pages connected to this study.